Palermo, Italy

Gennara Cavallaro

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gennara Cavallaro: Innovator in Ocular Drug Delivery Systems

Introduction

Gennara Cavallaro, an accomplished inventor based in Palermo, Italy, has made significant strides in the field of ocular therapeutics. With a total of three patents to his name, Cavallaro's work focuses on developing innovative nanostructured formulations aimed at enhancing the delivery of key active ingredients, including silibinin, for treating various ocular diseases.

Latest Patents

Cavallaro's most recent patents detail formulations that incorporate silibinin and other active ingredients within lipid nanoparticle systems, specifically of the Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) types. These formulations are notably based on calixarenes, which may be mucoadhesive, and take advantage of micellar and nanoparticle systems created from amphiphilic inulin copolymers. His research emphasizes the versatility of calixarene compounds, which are capable of efficiently carrying and releasing active ingredients that possess low water solubility, prone to easy chemical and enzymatic degradation, and have low bioavailability. This innovation is particularly relevant for developing treatments for neurodegenerative ocular diseases.

Career Highlights

As an inventor, Cavallaro is affiliated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where he contributes to advancing nanotechnology applications in medicine. His work significantly enhances the potential for new therapies to improve patient outcomes in the treatment of ocular conditions.

Collaborations

Throughout his career, Cavallaro has collaborated with notable colleagues including Anna Rita Blanco and Grazia Maria Letizia Consoli. These partnerships enhance the collaborative nature of his innovations and reflect a collective effort toward advancing ocular therapeutic solutions.

Conclusion

Gennara Cavallaro stands out as a pioneering figure in the realm of ocular drug delivery systems. His patented innovations not only highlight his expertise in nanotechnology but also underscore the potential for significant advancements in treatments for debilitating ocular diseases. Through collaboration and dedication, Cavallaro is poised to continue making impactful contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…